Abstract
Fibromyalgia is defined by widespread body pain, tenderness to palpation of tender point areas, and constitutional symptoms. The literature reports headache in about half of fibromyalgia patients. The current epidemiological study was designed to determine the prevalence and characteristics of headache in fibromyalgia patients. Treatment-seeking fibromyalgia patients were evaluated with measures for fibromyalgia, chronic headache, quality of life, and psychological distress. Multivariate analysis of variance (MANOVA) and t-tests were used to identify significant differences, as appropriate. A total of 100 fibromyalgia patients were screened (24 fibromyalgia without headache and 76 fibromyalgia with headache). International Headache Society diagnoses included: migraine alone (n=15 with aura, n=17 without aura), tension-type alone (n=18), combined migraine and tension-type (n=16), post-traumatic (n=4), and probable analgesic overuse headache (n=6). Fibromyalgia tender point scores and counts and most measures of pain severity, sleep disruption, or psychological distress were not significantly different between fibromyalgia patients with and without headache. As expected, the fibromyalgia patients with headache scored higher on the Headache Impact Test (HIT-6) (62.1±0.9 vs 48.3±1.6, p<0.001). HIT-6 scores were >60 in 80% of fibromyalgia plus headache patients, representing severe impact from headache, and 56–58 in 4%, representing substantial impact. In summary, chronic headache was endorsed by 76% of treatment-seeking fibromyalgia patients, with 84% reporting substantial or severe impact from their headaches. Migraine was diagnosed in 63% of fibromyalgia plus headache patients, with probable analgesic overuse headache in only 8%. General measures of pain, pain-related disability, sleep quality, and psychological distress were similar in fibromyalgia patients with and without headache. Therefore, fibromyalgia patients with headache do not appear to represent a significantly different subgroup compared to fibromyalgia patients without headache. The high prevalence and significant impact associated with chronic headache in fibromyalgia patients, however, warrants inclusion of a headache assessment as part of the routine evaluation of fibromyalgia patients.
Similar content being viewed by others
References
Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172
Wolfe F, Ross K, Anderson J, Russell IJ (1995) Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22:151–156
White KP, Speechley M, Harth M, Ostbye T (1999) Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study. Arthritis Rheum 42:76–83
Okifuji A, Turk DC, Marcus DA (1999) Comparison of generalized and localized hyperalgesia in patients with recurrent headache and fibromyalgia. Psychosom Med 61:771–780
Hudson JI, Goldenberg DL, Pope HG, Keck PE Jr, Schlesinger L (1992) Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92:363–367
Marcus DA (2003) Headache and other types of chronic pain. Headache 43:49–53
White KP, Nielson WR, Harth M, Ostbye T, Speechley M (2002) Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol 29:588–594
Aaron LA, Bradley LA, Alarcon GS et al (1996) Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 39:436–445
Peres MP, Young WB, Kaup AO, Zukerman E, Silberstein SD (2001) Fibromyalgia is common in patients with transformed migraine. Neurology 57:1326–1328
Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47:614–624
Wessely S, Nimnuan C, Sharpe M (1999) Functional somatic syndromes: one or many? Lancet 354:936–939
Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M (2001) How many functional somatic syndromes. J Psychosom Res 51:549–557
Wessely S, White PD (2004) There is only one functional somatic syndrome. Br J Psychiatry 185:95–96
Okifuji A, Turk DC, Sinclair JD, Starz TW, Marcus DA (1997) A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol 24:377–383
Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd edition. Cephalalgia 24 [Suppl 1]:1–160
Anderson KO, Dowds BN, Pelletz RE, Edwards WT, Peeters-Asdourian C (1995) Development and initial validation of a scale to measure self-efficacy beliefs in patients with chronic pain. Pain 63:77–84
Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Lustman PJ, Clouse RE, Griffith RM et al (1997) Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med 59:24–31
Leentjens AF, Verhey FR, Luijckx GJ, Troost J (2000) The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson’s disease. Mov Disord 15:1221–1224
Geisser ME, Roth RS, Robinson ME (1997) Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: a comparative analysis. Clin J Pain 13:163–170
Spielberger CD, Jacobs G, Crane R et al (1979) State-trait personality inventory. University of South Florida Human Resources Institute, Tampa, FL
Burckhardt CS, Clark SR, Bennett RM (1991) The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 18:728–734
Pryse-Phillips W (2002) Evaluating migraine disability: the headache impact test instrument in context. Can J Neurol Sci 29 [Suppl 2]:S11–S15
McCracken LM, Gross RT, Aiekns J, Carnrike CL Jr (1996) The assessment of anxiety and fear in persons with chronic pain: a comparison of instruments. Behav Res Ther 34:927–933
Elliott AM, Smith BH, Smith WC, Chambers WA (2000) Changes in chronic pain severity over time: the Chronic Pain Grade as a valid measure. Pain 88:303–308
Ware JE (1997) SF-36 Health Survey Manual and Interpretation Guide. The Health Institute, New England Medical Center, Boston
Bray JH, Maxwell SE (1985) Multivariate analysis of variance. Sage Publications, Beverly Hills, CA
Elashoff JD (2000) nQuery advisor version 4.0 user’s guide. Statistical Solutions Ltd, Los Angeles
Marcus DA (2003) Gender differences in chronic pain in a treatment-seeking population. J Gend Specif Med 6:19–24
Launer LJ, Terwindt GM, Ferrari MD (1999) The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 53:537–542
Lampl C, Buzath A, Baumhackl U, Klingler D (2003) One-year prevalence of migraine in Austria: a nationwide survey. Cephalalgia 23:280–286
Takeshima T, Ishikaki K, Fukahara Y et al (2004) Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache 44:8–19
Marcus DA (2000) Identification of patients with headache at risk of psychological distress. Headache 40:373–376
Marcus DA, Kapelewski C, Jacob RG, Rudy TE, Furman JM (2004) Validation of a brief nurse-administered migraine assessment tool. Headache 44:328–332
Stewart WF, Lipton RB, Whyte J et al (1999) An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53:988–994
Acknowledgments
This project was supported by grants from Elan Pharmaceuticals and the Raymond and Elizabeth Bloch Charitable and Educational Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marcus, D.A., Bernstein, C. & Rudy, T.E. Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome. Clin Rheumatol 24, 595–601 (2005). https://doi.org/10.1007/s10067-005-1121-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-1121-x